Next Article in Journal
A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
Next Article in Special Issue
Liposomes to Augment Dialysis in Preclinical Models: A Structured Review
Previous Article in Journal
Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy
Previous Article in Special Issue
Solid Lipid Particles for Lung Metastasis Treatment
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(1), 119; https://doi.org/10.3390/pharmaceutics13010119
Action Date Notes Link
article xml file uploaded 19 January 2021 09:45 CET Original file -
article xml uploaded. 19 January 2021 09:45 CET Update -
article pdf uploaded. 19 January 2021 09:45 CET Version of Record -
article supplementary file uploaded. 19 January 2021 09:45 CET - https://www.mdpi.com/1999-4923/13/1/119#supplementary
article html file updated 19 January 2021 09:46 CET Original file -
article xml file uploaded 19 January 2021 12:17 CET Update -
article xml uploaded. 19 January 2021 12:17 CET Update https://www.mdpi.com/1999-4923/13/1/119/xml
article pdf uploaded. 19 January 2021 12:17 CET Updated version of record https://www.mdpi.com/1999-4923/13/1/119/pdf
article html file updated 19 January 2021 12:19 CET Update -
article html file updated 20 January 2021 07:47 CET Update -
article html file updated 22 January 2021 10:40 CET Update -
article html file updated 23 July 2022 19:28 CEST Update https://www.mdpi.com/1999-4923/13/1/119/html
Back to TopTop